Trimodality Therapy in the Treatment of Stage III N2‐Positive Non‐Small Cell Lung Cancer: A National Cancer Database Analysis

BACKGROUND: Significant controversy remains regarding the care of patients with clinical stage III (N2‐positive) NSCLC. Although multimodality therapy is effective, the roles of surgery, chemotherapy, and radiotherapy are not fully defined and the optimal treatment approach is not firmly established...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Behera, Madhusmita, Steuer, Conor E., Liu, Yuan, Fernandez, Felix, Fu, Chao, Higgins, Kristin A., Gillespie, Theresa W., Pakkala, Suchita, Pillai, Rathi N., Force, Seth, Belani, Chandra P., Khuri, Fadlo R., Curran, Walter J., Ramalingam, Suresh S.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2020
Assuntos:
Lung Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7288644/
https://ncbi.nlm.nih.gov/pubmed/31943520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0661
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados